Loading chat...
FL H0963
Bill
Status
5/5/2023
Primary Sponsor
Gallop Franklin
Click for details
AI Summary
-
Licensed pharmacists may screen for HIV exposure and order and dispense HIV infection prevention drugs (preexposure prophylaxis, postexposure prophylaxis, and FDA-approved preventive drugs) under a written supervisory protocol with a physician or a statewide drug therapy protocol.
-
Pharmacists must be certified by the Board of Pharmacy before ordering or dispensing HIV prevention drugs, with certification developed in consultation with the Board of Medicine and Board of Osteopathic Medicine.
-
Certification requires pharmacists to hold an active pharmacy license, be actively practicing, hold a doctorate of pharmacy degree or have 5+ years of experience, maintain $250,000 liability coverage, and complete an approved course covering patient assessments, point-of-care testing, safe treatment, and contraindication identification.
-
The Board of Pharmacy must develop a statewide drug therapy protocol in consultation with medical boards and the Department of Health, considering physician referrals, lab testing, CDC guidelines for referrals and counseling, and patient follow-up care.
-
The act takes effect July 1, 2023.
Legislative Description
HIV Infection Prevention Drugs
Last Action
Died in Healthcare Regulation Subcommittee
5/5/2023